Glenmede Trust’s Nu Skin NUS Stock Holding History

Glenmede Trust’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$101K	Buy	+19,042	New	+$122K	﹤0.01%	1396
2020 Q4	–	Sell	-50	Closed	-$2K	–	1887
2020 Q3	$2K	Hold	50	–	–	﹤0.01%	2273
2020 Q2	$1K	Buy	+50	New	+$1.61K	﹤0.01%	2346
2018 Q4	–	Sell	-21,796	Closed	-$1.8M	–	3064
2018 Q3	$1.8M	Buy	21,796 +36	+0.2%	+$2.86K	0.01%	664
2018 Q2	$1.7M	Buy	21,760 +21,725	+62,071%	+$1.68M	0.01%	629
2018 Q1	$2K	Hold	35	–	–	﹤0.01%	2602
2017 Q4	$2K	Buy	+35	New	+$2.26K	﹤0.01%	2602
2014 Q3	–	Sell	-127	Closed	-$9K	–	2494
2014 Q2	$9K	Hold	127	–	–	﹤0.01%	2066
2014 Q1	$10K	Sell	127 -624	-83%	-$54.8K	﹤0.01%	2045
2013 Q4	$103K	Sell	751 -434	-37%	-$51.1K	﹤0.01%	1391
2013 Q3	$113K	Sell	1,185 -114,150	-99%	-$9.69M	﹤0.01%	1330
2013 Q2	$7.05M	Buy	+115,335	New	+$6.4M	0.09%	258

Other funds holding NUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Glenmede Trust's NUS Position: Q2 2026 in Review

Glenmede Trust opened a new position in Nu Skin (NUS) in Q2 2026: 19,042 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #1396 among its holdings. This is a return to the name: Glenmede Trust previously reported a position in NUS as recently as Q3 2020.

Glenmede Trust first reported a position in NUS in Q2 2013 and has held it in 12 quarters since. The position peaked at $7.05M in Q2 2013. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

Glenmede Trust held 19,042 shares of Nu Skin worth $101K as of Q2 2026.
Nu Skin was a new Glenmede Trust position in Q2 2026.
Nu Skin made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1396 holding.
Glenmede Trust first reported a position in Nu Skin in Q2 2013 and has held it in 12 quarters since.
Glenmede Trust's Nu Skin position peaked at $7.05M in Q2 2013.
162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.